TRS4Vision - A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma
Trial details
- Registry ID
- NCT05042609
- Drugs studied
- FDA approved steroid eye drop (masked), TRS01
TrialRedline tracks 1 clinical trial sponsored by Tarsier Pharma: 1 Phase 3.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| TRS4Vision - A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic GlaucomaNCT05042609 | FDA approved steroid eye drop (masked), TRS01 | Completed | 2023-06-29Actual |
Names as written in the registry records.